Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPRY2 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-17 |
mRNA | SH3TC2 | CTRPv2 | pan-cancer | AAC | 0.32 | 8e-15 |
mRNA | GKAP1 | CTRPv2 | pan-cancer | AAC | -0.28 | 1e-14 |
mRNA | SPECC1L-ADORA2A | CTRPv2 | pan-cancer | AAC | -0.26 | 1e-12 |
mRNA | LYST | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | ZFP36L2 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-12 |
mRNA | SLC35D2 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-12 |
mRNA | ACY1 | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-12 |
mRNA | SPRY4 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-11 |
mRNA | WDR76 | CTRPv2 | pan-cancer | AAC | -0.26 | 1e-11 |